IMNM
Immunome IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$2.08B
P/E Ratio
—
EPS
$-2.39
Beta
2.07
52W High
$27.65
52W Low
$7.96
50-Day MA
$21.82
200-Day MA
$19.17
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Immunome Inc
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapies for oncology and infectious diseases. The company is headquartered in Exton, Pennsylvania.
Fundamentals
| Revenue (TTM) | $4.01M |
| Gross Profit (TTM) | $-182.78M |
| EBITDA | $-226.35M |
| Operating Margin | -5699.00% |
| Return on Equity | -50.10% |
| Return on Assets | -29.70% |
| Revenue/Share (TTM) | $0.04 |
| Book Value | $5.20 |
| Price-to-Book | 3.54 |
| Price-to-Sales (TTM) | 518.44 |
| EV/Revenue | 374.23 |
| EV/EBITDA | -0.72 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $113.25M |
| Float | $108.33M |
| % Insiders | 6.30% |
| % Institutions | 108.35% |
Historical Volatility
HV 10-Day
50.14%
HV 20-Day
66.15%
HV 30-Day
57.16%
HV 60-Day
56.10%
HV Rank
35.7%
Volatility is currently contracting
Analyst Ratings
Consensus ($35.77 target)
3
Strong Buy12
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026